Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies.

Lhote R, Grenier P, Haroche J, Miyara M, Boussouar S, Mathian A, Pha M, Amoura Z, Cohen Aubart F.

J Clin Rheumatol. 2019 Aug 13. doi: 10.1097/RHU.0000000000001127. [Epub ahead of print]

PMID:
31415476
2.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Aug 10. doi: 10.1007/s10875-019-00658-9. [Epub ahead of print]

PMID:
31401750
3.

Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter.

Sbeih N, Mathian A, Pineton de Chambrun M, Lhote R, Zahr N, Pha M, Cohen-Aubart F, Haroche J, Hié M, Jouffroy S, Benameur N, Devilliers H, Amoura Z.

Ann Rheum Dis. 2019 Jul 8. pii: annrheumdis-2019-215732. doi: 10.1136/annrheumdis-2019-215732. [Epub ahead of print] No abstract available.

PMID:
31285257
4.

Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease): less is more-comment.

Pineton de Chambrun M, Mathian A, Combes A, Luyt CE, Amoura Z.

Intern Emerg Med. 2019 Jul 4. doi: 10.1007/s11739-019-02144-x. [Epub ahead of print] No abstract available.

PMID:
31273675
5.

Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans Cell Histiocytosis.

Sagna Y, Courtillot C, Drabo JY, Tazi A, Donadieu J, Idbaih A, Cohen F, Amoura Z, Haroche J, Touraine P.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0177.R2. doi: 10.1530/EJE-19-0177. [Epub ahead of print]

PMID:
31269469
6.

CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.

Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Combes A, Luyt CE, Amoura Z; SAPHIR study group.

J Autoimmun. 2019 Jun 26:102292. doi: 10.1016/j.jaut.2019.06.003. [Epub ahead of print] Review.

PMID:
31253464
7.

Intractable Nausea and Vomiting: Gut Is Not Always the Answer.

Frapard T, Amoura Z, Pineton de Chambrun M.

Am J Med. 2019 Jun 23. pii: S0002-9343(19)30528-5. doi: 10.1016/j.amjmed.2019.05.046. [Epub ahead of print] No abstract available.

PMID:
31242437
8.

Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.

Nielly H, Mathian A, Cazenave M, Izzedine H, Haroche J, Cohen-Aubart F, Hie M, Miyara M, Pineton de Chambrun M, Benameur N, Hausfater P, Pha M, Boutin-Lê Thi Huong D, Rouvier P, Brocheriou I, Cluzel P, Amoura Z.

Nephrol Dial Transplant. 2019 Jun 3. pii: gfz085. doi: 10.1093/ndt/gfz085. [Epub ahead of print]

PMID:
31157889
9.

Erdheim-Chester Disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1.

Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F, Hélias-Rodzewicz Z, Goyal G, Go RS, Dogan A, Abdel-Wahab O, Durham B, Ozkaya N, Amoura Z, Emile JF, Haroche J.

Haematologica. 2019 May 23. pii: haematol.2019.216937. doi: 10.3324/haematol.2019.216937. [Epub ahead of print]

10.

Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J.

Curr Oncol Rep. 2019 May 21;21(7):62. doi: 10.1007/s11912-019-0810-6. Review.

PMID:
31115724
11.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 May 15. pii: annrheumdis-2019-215213. doi: 10.1136/annrheumdis-2019-215213. [Epub ahead of print]

PMID:
31092409
12.

The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.

Chazal T, Costopoulos M, Maillart E, Fleury C, Psimaras D, Legendre P, Pineton de Chambrun M, Haroche J, Lubetzki C, Amoura Z, Legarff-Tavernier M, Cohen Aubart F.

Eur J Neurol. 2019 Apr 25. doi: 10.1111/ene.13975. [Epub ahead of print]

PMID:
31021023
13.

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.

Amoura A, Haroche J, Emile JF, Barete S, Helias-Rodzewicz Z, Charlotte F, Maisonobe T, Amoura Z, Cohen Aubart F.

J Eur Acad Dermatol Venereol. 2019 Apr 19. doi: 10.1111/jdv.15636. [Epub ahead of print] No abstract available.

PMID:
31002424
14.

[Coronary involvement and nephrotic syndrome in systemic lupus: A case report].

Moyon Q, Schmidt M, Hertig A, Fouret P, Vauthier-Brouzes D, Amoura Z, Cohen Aubart F.

Rev Med Interne. 2019 Jun;40(6):395-399. doi: 10.1016/j.revmed.2019.03.001. Epub 2019 Apr 10. French.

PMID:
30981562
15.

Expanding the spectrum of HIV-associated myopathy.

Landon-Cardinal O, Gallay L, Dubourg O, Maisonobe T, Léonard-Louis S, Beniken D, Simon A, Behin A, Stojkovic T, Duyckaerts C, Breton G, Rigolet A, Fain O, Meyohas MC, Leport C, Valantin MA, Vittecoq D, Bergmann JF, Hanslik T, Chauveheid MP, Amoura Z, de Broucker T, Eymard B, Beaudequin N, Benveniste O, Allenbach Y.

J Neurol Neurosurg Psychiatry. 2019 Apr 11. pii: jnnp-2018-319419. doi: 10.1136/jnnp-2018-319419. [Epub ahead of print] No abstract available.

PMID:
30975823
16.

Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.

Roeser A, Cohen-Aubart F, Breillat P, Miyara M, Emile JF, Charlotte F, Donadieu J, Amoura Z, Haroche J.

Haematologica. 2019 Mar 28. pii: haematol.2018.214007. doi: 10.3324/haematol.2018.214007. [Epub ahead of print]

17.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

18.

Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.

Noé G, Amoura Z, Combarel D, Lori L, Tissot N, Seycha A, Funck-Brentano C, Zahr N.

Ther Drug Monit. 2019 Aug;41(4):476-482. doi: 10.1097/FTD.0000000000000614.

PMID:
30807538
19.

Renal toxicities associated with pembrolizumab.

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.

Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.

20.

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Riller Q, Cotteret C, Junot H, Benameur N, Haroche J, Mathian A, Hie M, Miyara M, Tilleul P, Amoura Z, Cohen Aubart F.

J Neurol. 2019 May;266(5):1073-1078. doi: 10.1007/s00415-019-09234-y. Epub 2019 Feb 9.

PMID:
30739183
21.

IgG4-related diseases: state of the art on clinical practice guidelines.

Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A, Faiz K, Frank C, Hachulla E, Hie M, Launay D, Montecucco C, Monti S, Mouthon L, Tincani A, Toniati P, Van Hagen PM, Van Vollenhoven RF, Bombardieri S, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Alexander T.

RMD Open. 2019 Jan 19;4(Suppl 1):e000787. doi: 10.1136/rmdopen-2018-000787. eCollection 2018. Review.

22.

Long-bones involvement in generalized crystal-storing histiocytosis.

Michon A, Cohen Aubart F, Haroche J, Charlotte F, Maksud P, Amoura Z.

Joint Bone Spine. 2019 Jan 25. pii: S1297-319X(18)30204-5. doi: 10.1016/j.jbspin.2019.01.006. [Epub ahead of print] No abstract available.

PMID:
30685538
23.

Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study.

Grimaud F, Yelnik C, Pineton de Chambrun M, Amoura Z, Arnaud L, Costedoat Chalumeau N, Hachulla E, Lambert M, Roriz M, Sibilia J, Papo T, Sacre K.

Rheumatology (Oxford). 2019 Jun 1;58(6):1006-1010. doi: 10.1093/rheumatology/key437.

PMID:
30608611
24.

Transvenous Renal Biopsy of Critically Ill Patients: Safety and Diagnostic Yield.

de Chambrun MP, Cluzel P, Brocheriou I, Bréchot N, Hékimian G, Turki MW, Franchineau G, Rouvier P, Bourcier S, Bureau C, Nieszkowska A, Le Guennec L, Mathian A, Amoura Z, Schmidt M, Combes A, Luyt CE.

Crit Care Med. 2019 Mar;47(3):386-392. doi: 10.1097/CCM.0000000000003634.

PMID:
30608282
25.

Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature.

Arnaud L, Gavand PE, Voll R, Schwarting A, Maurier F, Blaison G, Magy-Bertrand N, Pennaforte JL, Peter HH, Kieffer P, Bonnotte B, Poindron V, Fiehn C, Lorenz H, Amoura Z, Sibilia J, Martin T.

Rheumatology (Oxford). 2019 Jun 1;58(6):987-996. doi: 10.1093/rheumatology/key398.

PMID:
30597077
26.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

27.

Synergistic convergence of microbiota-specific systemic IgG and secretory IgA.

Fadlallah J, Sterlin D, Fieschi C, Parizot C, Dorgham K, El Kafsi H, Autaa G, Ghillani-Dalbin P, Juste C, Lepage P, Malphettes M, Galicier L, Boutboul D, Clément K, André S, Marquet F, Tresallet C, Mathian A, Miyara M, Oksenhendler E, Amoura Z, Yssel H, Larsen M, Gorochov G.

J Allergy Clin Immunol. 2019 Apr;143(4):1575-1585.e4. doi: 10.1016/j.jaci.2018.09.036. Epub 2018 Dec 13.

PMID:
30554723
28.

Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.

Mathian A, Mouries-Martin S, Dorgham K, Devilliers H, Barnabei L, Ben Salah E, Cohen-Aubart F, Garrido Castillo L, Haroche J, Hie M, Pineton de Chambrun M, Miyara M, Sterlin D, Pha M, Lê Thi Huong D, Rieux-Laucat F, Rozenberg F, Gorochov G, Amoura Z.

Arthritis Rheumatol. 2019 May;71(5):756-765. doi: 10.1002/art.40792.

PMID:
30507062
29.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

30.

Mixed connective tissue disease: state of the art on clinical practice guidelines.

Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R.

RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.

31.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
32.

Giant-cell arteritis-related mortality in France: A multiple-cause-of-death analysis.

Chazal T, Lhote R, Rey G, Haroche J, Eb M, Amoura Z, Cohen Aubart F.

Autoimmun Rev. 2018 Dec;17(12):1219-1224. doi: 10.1016/j.autrev.2018.06.012. Epub 2018 Oct 11. Review.

33.

Highly sensitive methods are required to detect mutations in histiocytoses.

Melloul S, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Fraitag S, Terrones N, Riller Q, Chazal T, Héritier S, Moreau A, Kambouchner M, Copin MC, Donadieu J, Taly V, Amoura Z, Haroche J, Emile JF.

Haematologica. 2019 Mar;104(3):e97-e99. doi: 10.3324/haematol.2018.201194. Epub 2018 Sep 27. No abstract available.

34.

Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition.

Miyara M, Charuel JL, Mudumba S, Wu A, Ghillani-Dalbin P, Amoura Z, Burlingame RW, Musset L.

PLoS One. 2018 Aug 30;13(8):e0202736. doi: 10.1371/journal.pone.0202736. eCollection 2018.

35.

Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis.

Jachiet V, Lhote R, Rufat P, Pha M, Haroche J, Crozier S, Dupel-Potier C, Psimaras D, Amoura Z, Cohen Aubart F.

J Neurol. 2018 Oct;265(10):2333-2341. doi: 10.1007/s00415-018-9001-x. Epub 2018 Aug 14.

36.

Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients.

Mekinian A, Maisonobe L, Boukari L, Melenotte C, Terrier B, Ayrignac X, Schleinitz N, Sène D, Hamidou M, Konaté A, Guilpain P, Abisror N, Ghrenassia E, Lachenal F, Cevallos R, Roos-Weil R, Du LTH, Lhote F, Larroche C, Bergmann JF, Humbert S, Fraison JB, Piette JC, Guillevin L, Dhote R, Amoura Z, Haroche J, Fain O.

Medicine (Baltimore). 2018 Jul;97(30):e11413. doi: 10.1097/MD.0000000000011413. Erratum in: Medicine (Baltimore). 2018 Aug;97(33):e12063.

37.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

Cohen-Aubart F, Guerin M, Poupel L, Cluzel P, Saint-Charles F, Charlotte F, Arsafi Y, Emile JF, Frisdal E, Le Goff C, Donadieu J, Amoura Z, Lesnik P, Haroche J, Le Goff W.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1913-1925. doi: 10.1161/ATVBAHA.118.310803.

PMID:
29930009
38.

Lupus and vaccinations.

Mathian A, Pha M, Amoura Z.

Curr Opin Rheumatol. 2018 Sep;30(5):465-470. doi: 10.1097/BOR.0000000000000525. Review.

PMID:
29889693
39.

Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Cohen Aubart F, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452. doi: 10.1212/NXI.0000000000000452. eCollection 2018 May.

40.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
41.

Microbial ecology perturbation in human IgA deficiency.

Fadlallah J, El Kafsi H, Sterlin D, Juste C, Parizot C, Dorgham K, Autaa G, Gouas D, Almeida M, Lepage P, Pons N, Le Chatelier E, Levenez F, Kennedy S, Galleron N, de Barros JP, Malphettes M, Galicier L, Boutboul D, Mathian A, Miyara M, Oksenhendler E, Amoura Z, Doré J, Fieschi C, Ehrlich SD, Larsen M, Gorochov G.

Sci Transl Med. 2018 May 2;10(439). pii: eaan1217. doi: 10.1126/scitranslmed.aan1217.

PMID:
29720448
42.

More on Ofatumumab for TTP.

Cohen Aubart F, Haroche J, Amoura Z.

N Engl J Med. 2018 Apr 5;378(14):1364-5. doi: 10.1056/NEJMc1801263. No abstract available.

PMID:
29619817
43.

Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.

Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutémy J, Espitia O, Bouillet L, Berthier S, Gaultier JB, Jeandel PY, Konaté A, Mékinian A, Solau-Gervais E, Terrier B, Wendling D, Andry F, Garnier C, Cathébras P, Arnaud L, Palmaro A, Cacoub P, Amoura Z, Piette JC, Arlet P, Lapeyre-Mestre M, Sailler L.

Ann Rheum Dis. 2018 Aug;77(8):1172-1178. doi: 10.1136/annrheumdis-2017-212705. Epub 2018 Mar 13.

PMID:
29535124
44.

Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.

Cheng LE, Amoura Z, Cheah B, Hiepe F, Sullivan BA, Zhou L, Arnold GE, Tsuji WH, Merrill JT, Chung JB.

Arthritis Rheumatol. 2018 Jul;70(7):1071-1076. doi: 10.1002/art.40479. Epub 2018 May 25.

45.

[Rosai-Dorfman disease: Diagnosis and therapeutic challenges].

Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z.

Rev Med Interne. 2018 Aug;39(8):635-640. doi: 10.1016/j.revmed.2018.02.011. Epub 2018 Mar 1. Review. French.

PMID:
29501513
46.

Myocardial dysfunction is frequent in systemic capillary-leak syndrome (Clarkson disease) severe episodes.

Pineton de Chambrun M, Mathian A, Luyt CE, Combes A, Amoura Z; EurêClark Study Group.

J Allergy Clin Immunol. 2018 Apr;141(4):1539-1540. doi: 10.1016/j.jaci.2017.11.055. Epub 2018 Feb 21. No abstract available.

PMID:
29477581
47.

Inclusion body myositis and human immunodeficiency virus type 1: A new case report and literature review.

Couture P, Malfatti E, Morau G, Mathian A, Cohen-Aubart F, Nielly H, Amoura Z, Cherin P.

Neuromuscul Disord. 2018 Apr;28(4):334-338. doi: 10.1016/j.nmd.2018.01.005. Epub 2018 Jan 10.

PMID:
29426734
48.

Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.

Cohen-Aubart F, Emile JF, Carrat F, Helias-Rodzewicz Z, Taly V, Charlotte F, Cluzel P, Donadieu J, Idbaih A, Barete S, Amoura Z, Haroche J.

Am J Hematol. 2018 May;93(5):E114-E117. doi: 10.1002/ajh.25055. Epub 2018 Feb 10. No abstract available.

49.

Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Couture P, Chazal T, Rosso C, Haroche J, Léger A, Hervier B, Deltour S, Amoura Z, Cohen Aubart F.

J Neurol. 2018 Apr;265(4):757-763. doi: 10.1007/s00415-018-8744-8. Epub 2018 Feb 1.

PMID:
29392458
50.

Efficacy of infliximab in the treatment of Erdheim-Chester disease.

Cohen-Aubart F, Maksud P, Emile JF, Benameur N, Charlotte F, Cluzel P, Amoura Z, Haroche J.

Ann Rheum Dis. 2018 Sep;77(9):1387-1390. doi: 10.1136/annrheumdis-2017-212678. Epub 2018 Jan 23. No abstract available.

PMID:
29363511

Supplemental Content

Loading ...
Support Center